Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C5H6N2 |
| Molecular Weight | 94.1145 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC=CC=C1
InChI
InChIKey=ICSNLGPSRYBMBD-UHFFFAOYSA-N
InChI=1S/C5H6N2/c6-5-3-1-2-4-7-5/h1-4H,(H2,6,7)
| Molecular Formula | C5H6N2 |
| Molecular Weight | 94.1145 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| N-glycan structures of human transferrin produced by Lymantria dispar (gypsy moth) cells using the LdMNPV expression system. | 2003-07 |
|
| Investigations into the interactions between DNA and conformationally constrained pyridylamineplatinum(II) analogues of AMD473. | 2003-06-02 |
|
| Speciation study of the anti-inflammatory drug tenoxicam (Htenox) with Cu(II): X-ray crystal structure of [Cu(tenox)(2)(py)(2)].EtOH. | 2003-06-01 |
|
| Localization of defined carbohydrate epitopes in bovine polysialylated NCAM. | 2003-05-27 |
|
| Regioselective substitution of 6,7-dichloroquinoline-5,8-dione: synthesis and X-ray crystal structure of 4a,10,11-triazabenzo[3,2-a]fluorene-5,6-diones. | 2003-04-17 |
|
| Distance dependence of electron transfer across peptides with different secondary structures: the role of Peptide energetics and electronic coupling. | 2003-04-02 |
|
| Thermodynamic, kinetic and structural studies on the mixed ligand complexes of palladium(II) with tridentate and monodentate ligands. | 2003-03-01 |
|
| Bis(2-aminopyridinium) maleate. | 2003-03 |
|
| Plant cultured cells expressing human beta1,4-galactosyltransferase secrete glycoproteins with galactose-extended N-linked glycans. | 2003-03 |
|
| Substituted aminopyridines as potent and selective phosphodiesterase-4 inhibitors. | 2003-02-24 |
|
| Structural modulation of Cu(I) and Cu(II) complexes of sterically hindered tripyridine ligands by the bridgehead alkyl groups. | 2003-02-24 |
|
| Magnetic interaction of pyridyl-substituted thioaminyl stable free radicals. | 2003-02-21 |
|
| Reduced inotropic heart response in selenium-deficient mice relates with inducible nitric oxide synthase. | 2003-02 |
|
| NMR evaluation of the configurational stability of Cu(I) complexes. | 2003-01-27 |
|
| An HIV reverse transcriptase-selective nucleoside chain terminator. | 2003-01-22 |
|
| Syntheses and structures of isoindoline complexes of Zn(II) and Cu(II): an unexpected trinuclear Zn(II) complex. | 2003-01-13 |
|
| Structural chemistry and In vitro antitubercular activity of acetylpyridine benzoyl hydrazone and its copper complex against Mycobacterium smegmatis. | 2003-01-06 |
|
| Could redox-switched binding of a redox-active ligand to a copper(II) centre drive a conformational proton pump gate? A synthetic model study. | 2003-01-03 |
|
| Selective complex formation of some chromogenic calix[4]arene derivatives detected by Fourier transform infrared spectroscopy 1. Solution experiments. | 2003-01-01 |
|
| 2-aminopyridinium benzoate. | 2003-01 |
|
| Syntheses and magnetic properties of hexanuclear [Cp2Mn3(L1)4]2 and octanuclear [Mn8(L2)12(mu 4-O)2] (L1 = 2-HNC5H5N, L2 = 2-NH-3-Br-5-MeC5H3N, Cp = C5H5). | 2002-12-21 |
|
| [N.1.1]-(2,6)-Pyridinophanes: a new ligand type imposing unusual metal coordination geometries. | 2002-12-16 |
|
| Hydrogen bond vibrations of 2-aminopyridine.2-pyridone, a Watson-Crick analogue of adenine.uracil. | 2002-12-04 |
|
| Analysis of fluorogenic Smith degradation products of 7-(1,3-disulfonaphtyl)amino-disaccharides for linkage position analysis of carbohydrates. | 2002-12 |
|
| Antitumor agents. 2. Synthesis, structure-activity relationships, and biological evaluation of substituted 5H-pyridophenoxazin-5-ones with potent antiproliferative activity. | 2002-11-21 |
|
| Antitumor agents. 1. Synthesis, biological evaluation, and molecular modeling of 5H-pyrido[3,2-a]phenoxazin-5-one, a compound with potent antiproliferative activity. | 2002-11-21 |
|
| Amination of pyridylketenes: experimental and computational studies of strong amide enol stabilization by the 2-pyridyl group. | 2002-11-20 |
|
| Example of highly stereoregulated ruthenium amidine complex formation: synthesis, crystal structures, and spectral and redox properties of the complexes [Ru(II)(trpy)[NC(5)H(4)-CH=N-N(C(6)H(5))C(CH(3))=NH]](ClO(4))(2) (1) and [Ru(II)(trpy)(NC(5)H(4)-CH=N-NH-C(6)H(5))Cl]ClO(4) (2) (trpy = 2,2':6',2"-terpyridine). | 2002-11-04 |
|
| Synthesis and characterization of new linear pi-conjugated molecules containing bis(ethynylpyridine) units with a benzothiadiazole spacer. | 2002-11-01 |
|
| Synthesis of some novel quinoline-3-carboxylic acids and pyrimidoquinoline derivatives as potential antimicrobial agents. | 2002-11 |
|
| 2-Aminopyridinium-succinate-succinic acid (2/1/1). | 2002-11 |
|
| Solid-phase synthesis of imidazo[1,2-a]pyridine using sodium benzenesulfinate as a traceless linker. | 2002-10-31 |
|
| The unusual role of CO transfer in molybdenum-catalyzed asymmetric alkylations. | 2002-10-30 |
|
| Ru3(CO)12-catalyzed C-H/CO/olefin coupling of N-pyridylindolines. Direct carbonylation at a C-H bond delta to the pyridine nitrogen. | 2002-10-18 |
|
| Homoazanicotine: a structure-affinity study for nicotinic acetylcholine (nACh) receptor binding. | 2002-10-10 |
|
| X-ray diffraction and (1)H NMR in solution: structural determination of lanthanide complexes of a Py(2)N(6)Ac(4) ligand. | 2002-10-07 |
|
| Potent and selective inhibitors of PDGF receptor phosphorylation. 2. Synthesis, structure activity relationship, improvement of aqueous solubility, and biological effects of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives. | 2002-09-26 |
|
| Enzymatic synthesis and characterization of oligosaccharides structurally related to the repeating unit of Pullulan. | 2002-09-20 |
|
| A mild method for the formation and in situ reaction of imidoyl chlorides: conversion of pyridine-1-oxides to 2-aminopyridine amides. | 2002-09-05 |
|
| Site of protonation of nicotine and nornicotine in the gas phase: pyridine or pyrrolidine nitrogen? | 2002-09-04 |
|
| N-glucuronidation of nicotine and cotinine in human: formation of cotinine glucuronide in liver microsomes and lack of catalysis by 10 examined UDP-glucuronosyltransferases. | 2002-09 |
|
| Alkylation reactions of [WS(4)](2)(-) and [(eta(5)-C(5)Me(5))WS(3)](-) with 2,6-bis(bromomethyl)pyridine: the first isolation of bisalkylated tetrathiometalate WS(2)[2,6-(SCH(2))(2)(C(5)H(3)N)]. | 2002-08-12 |
|
| Studies on synthesis and infrared and fluorescence spectra of new europium and terbium complexes with an amide-based open-chain crown ether. | 2002-08 |
|
| Co(II)-regulated substrate specificity of cytosolic alpha-mannosidase. | 2002-08 |
|
| Nucleophilic attack at pyridine nitrogen and its use to access a novel mono-anionic ligand for iron-based ethylene polymerisation catalysts. | 2002-07-21 |
|
| Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI). | 2002-07-18 |
|
| Examination of molar-based distribution of A, B and C chains of amylopectin by fluorescent labeling with 2-aminopyridine. | 2002-07-16 |
|
| Exploring routes to stabilize a cationic pyridoxamine in an artificial transaminase: site-directed mutagenesis versus synthetic cofactors. | 2002-07 |
|
| New stereoselective reaction of methylglyoxal with 2-aminopyridine and adenine derivatives: formation of imino acid-nucleic base derivatives in water under mild conditions. | 2002-05-21 |
|
| Properties of some alkyl substituted phthalocyanines and related macrocycles. | 2002 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:45:09 GMT 2025
by
admin
on
Mon Mar 31 18:45:09 GMT 2025
|
| Record UNII |
WSX981HEWU
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000142926
Created by
admin on Mon Mar 31 18:45:09 GMT 2025 , Edited by admin on Mon Mar 31 18:45:09 GMT 2025
|
PRIMARY | |||
|
2068
Created by
admin on Mon Mar 31 18:45:09 GMT 2025 , Edited by admin on Mon Mar 31 18:45:09 GMT 2025
|
PRIMARY | |||
|
m1739
Created by
admin on Mon Mar 31 18:45:09 GMT 2025 , Edited by admin on Mon Mar 31 18:45:09 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID0024505
Created by
admin on Mon Mar 31 18:45:09 GMT 2025 , Edited by admin on Mon Mar 31 18:45:09 GMT 2025
|
PRIMARY | |||
|
504-29-0
Created by
admin on Mon Mar 31 18:45:09 GMT 2025 , Edited by admin on Mon Mar 31 18:45:09 GMT 2025
|
PRIMARY | |||
|
10439
Created by
admin on Mon Mar 31 18:45:09 GMT 2025 , Edited by admin on Mon Mar 31 18:45:09 GMT 2025
|
PRIMARY | |||
|
C032439
Created by
admin on Mon Mar 31 18:45:09 GMT 2025 , Edited by admin on Mon Mar 31 18:45:09 GMT 2025
|
PRIMARY | |||
|
431
Created by
admin on Mon Mar 31 18:45:09 GMT 2025 , Edited by admin on Mon Mar 31 18:45:09 GMT 2025
|
PRIMARY | |||
|
2-AMINOPYRIDINE
Created by
admin on Mon Mar 31 18:45:09 GMT 2025 , Edited by admin on Mon Mar 31 18:45:09 GMT 2025
|
PRIMARY | |||
|
207-988-4
Created by
admin on Mon Mar 31 18:45:09 GMT 2025 , Edited by admin on Mon Mar 31 18:45:09 GMT 2025
|
PRIMARY | |||
|
1544519
Created by
admin on Mon Mar 31 18:45:09 GMT 2025 , Edited by admin on Mon Mar 31 18:45:09 GMT 2025
|
PRIMARY | |||
|
WSX981HEWU
Created by
admin on Mon Mar 31 18:45:09 GMT 2025 , Edited by admin on Mon Mar 31 18:45:09 GMT 2025
|
PRIMARY | |||
|
SUB117598
Created by
admin on Mon Mar 31 18:45:09 GMT 2025 , Edited by admin on Mon Mar 31 18:45:09 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY | |||
|
PARENT -> IMPURITY |
correction factors: for the calculation of content, multiply the peak areas of the following impurities by the corresponding correction factor: impurity A = 0.2
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|